Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.
Ledys, Fanny
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale. [electronic resource] - Advances in therapy 06 2019 - 1480-1484 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1865-8652
10.1007/s12325-019-00949-y doi
Adult
Aged
Aged, 80 and over
Animals
Antineoplastic Agents--therapeutic use
Cetuximab--therapeutic use
Colorectal Neoplasms--drug therapy
ErbB Receptors--antagonists & inhibitors
Female
Humans
Male
Mice
Middle Aged
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Neoplasm Metastasis--drug therapy
Proto-Oncogene Proteins B-raf--drug effects
Pyridones--therapeutic use
Pyrimidinones--therapeutic use
Rats
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale. [electronic resource] - Advances in therapy 06 2019 - 1480-1484 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1865-8652
10.1007/s12325-019-00949-y doi
Adult
Aged
Aged, 80 and over
Animals
Antineoplastic Agents--therapeutic use
Cetuximab--therapeutic use
Colorectal Neoplasms--drug therapy
ErbB Receptors--antagonists & inhibitors
Female
Humans
Male
Mice
Middle Aged
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Neoplasm Metastasis--drug therapy
Proto-Oncogene Proteins B-raf--drug effects
Pyridones--therapeutic use
Pyrimidinones--therapeutic use
Rats